Nisa Investment Advisors’s Biohaven BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$85.6K Sell
5,750
-850
-13% -$9.15K ﹤0.01% 1626
2026
Q1
$55.8K Buy
6,600
+4,670
+242% +$51.1K ﹤0.01% 1620
2025
Q4
$21.8K Sell
1,930
-22,045
-92% -$273K ﹤0.01% 1915
2025
Q3
$360K Buy
23,975
+21,104
+735% +$307K ﹤0.01% 1108
2025
Q2
$40.5K Sell
2,871
-5,100
-64% -$90.9K ﹤0.01% 1650
2025
Q1
$192K Buy
7,971
+317
+4% +$11.2K ﹤0.01% 1239
2024
Q4
$286K Sell
7,654
-33
-0.4% -$1.54K ﹤0.01% 1196
2024
Q3
$384K Sell
7,687
-5,051
-40% -$197K ﹤0.01% 1122
2024
Q2
$442K Buy
12,738
+68
+0.5% +$2.69K ﹤0.01% 1120
2024
Q1
$693K Buy
12,670
+59
+0.5% +$2.92K ﹤0.01% 980
2023
Q4
$540K Hold
12,611
﹤0.01% 1029
2023
Q3
$328K Sell
12,611
-3,550
-22% -$73.8K ﹤0.01% 1187
2023
Q2
$387K Buy
16,161
+1,839
+13% +$31.7K ﹤0.01% 1151
2023
Q1
$196K Sell
14,322
-73,240
-84% -$1.17M ﹤0.01% 1310
2022
Q4
$1.22M Buy
87,562
+84,170
+2,481% +$1.19M 0.01% 860
2022
Q3
$35K Buy
+3,392
New +$24.6K ﹤0.01% 1871

Other funds holding BHVN

Nisa Investment Advisors's BHVN Position: Q2 2026 in Review

Nisa Investment Advisors reduced its Biohaven (BHVN) stake by 13% in Q2 2026, selling an estimated $9.15K and leaving 5,750 shares worth $85.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1626.

Nisa Investment Advisors first reported a position in BHVN in Q3 2022 and has held it in 16 quarters since. The position peaked at $1.22M in Q4 2022. 113 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.

  • Nisa Investment Advisors held 5,750 shares of Biohaven worth $85.6K as of Q2 2026.
  • Nisa Investment Advisors sold 850 Biohaven shares in Q2 2026, an estimated $9.15K.
  • Biohaven made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #1626 holding.
  • Nisa Investment Advisors first reported a position in Biohaven in Q3 2022 and has held it in 16 quarters since.
  • Nisa Investment Advisors's Biohaven position peaked at $1.22M in Q4 2022.
  • 113 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.